Zdrowie i gospodarka · 20/08/2026
FDA Renews Endocrinologic and Metabolic Drugs Advisory Committee for 2 Years
The FDA has renewed the Endocrinologic and Metabolic Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on August 27, 2028.